본문 바로가기
KERD
논문KCI 등재

한국어판 정신분열병의 캘거리 우울증 척도의 신뢰도 및 타당도 연구

A Study on the Reliability and Validity of the Korean Version of the Calgary Depression Scale for Schizophrenia (K-CDSS)

2

조회

0

다운로드

24

인용

0

참고문헌

주제분류정신과학

초록

Objectives:This study was performed to standardize the Korean Version of Calgary Depression Scale for Schizophrenia (K-CDSS), a semi-structured interview scale to assess depression in schizophrenia patients and to determine the psychometric properties and clinical utility of the K-CDSS. Methods:Sixty-one patients diagnosed as schizophrenia by DSM-IV criteria were recruited in this study. Then, the patients were interviewed using the Structure Clinical Interview for DSM-IV (SCID) by a trained psychologist. Subsequently, the KCDSS, Positive and Negative Syndrome Scale (PANSS), Hamilton Depression Rating Scale (HDRS), Montgomery-Åsberg Depression Rating Scale (MADRS) and Simpson Angus Rating Scale (SAS) were administered by a psychiatrist. Lastly, the K-CDSS was re-assessed by a second independent rater without any previous information of patients to confirm the inter-rater reliability. Results:The internal consistency using Cronbach’s α was 0.852. Inter-rater reliability using Intraclass Correlation Coefficient (ICC) for single items and for sum score were 0.659-0.889 and 0.963, respectively. K-CDSS was assessed by a second Factor analysis and ROC (receiver operating characteristic) curve analysis were conducted . The factor analysis revealed a single factor that accounted for 53.7% of the total variance, suggesting that the uni-dimensional structure of the K-CDSS may be retained. In addition, K-CDSS showed a good convergent validity with very strong correlations with HDRS (r=0.75) and MADRS (r=0.81), respectively. However, K-CDSS was not correlated with PANSS-positive, PANSS-negative and SAS, demonstrating its satisfactory discriminant validity. The area under the ROC curve was 0.968 (standard error=0.036, p<.001). With a cut-off point of 8, the K-CDSS had a sensitivity 83.3%, specificity 97.9%, positive predictive value 90.9% and negative predictive value 95.8%. Conclusion:K-CDSS is considered as a short and valid tool to identify depressive symptoms in schizophrenia. (J Korean Neuropsychiatr Assoc 2005;44(4):446-455)

Abstract

Objectives:This study was performed to standardize the Korean Version of Calgary Depression Scale for Schizophrenia (K-CDSS), a semi-structured interview scale to assess depression in schizophrenia patients and to determine the psychometric properties and clinical utility of the K-CDSS. Methods:Sixty-one patients diagnosed as schizophrenia by DSM-IV criteria were recruited in this study. Then, the patients were interviewed using the Structure Clinical Interview for DSM-IV (SCID) by a trained psychologist. Subsequently, the KCDSS, Positive and Negative Syndrome Scale (PANSS), Hamilton Depression Rating Scale (HDRS), Montgomery-Åsberg Depression Rating Scale (MADRS) and Simpson Angus Rating Scale (SAS) were administered by a psychiatrist. Lastly, the K-CDSS was re-assessed by a second independent rater without any previous information of patients to confirm the inter-rater reliability. Results:The internal consistency using Cronbach’s α was 0.852. Inter-rater reliability using Intraclass Correlation Coefficient (ICC) for single items and for sum score were 0.659-0.889 and 0.963, respectively. K-CDSS was assessed by a second Factor analysis and ROC (receiver operating characteristic) curve analysis were conducted . The factor analysis revealed a single factor that accounted for 53.7% of the total variance, suggesting that the uni-dimensional structure of the K-CDSS may be retained. In addition, K-CDSS showed a good convergent validity with very strong correlations with HDRS (r=0.75) and MADRS (r=0.81), respectively. However, K-CDSS was not correlated with PANSS-positive, PANSS-negative and SAS, demonstrating its satisfactory discriminant validity. The area under the ROC curve was 0.968 (standard error=0.036, p<.001). With a cut-off point of 8, the K-CDSS had a sensitivity 83.3%, specificity 97.9%, positive predictive value 90.9% and negative predictive value 95.8%. Conclusion:K-CDSS is considered as a short and valid tool to identify depressive symptoms in schizophrenia. (J Korean Neuropsychiatr Assoc 2005;44(4):446-455)

참고문헌 (30)

  1. "Pyramidical model of schizophrenia", 16, pp.537~545
  2. "Diagnosis of secondary depression in schizophrenia:implicationsfor DSM-IV", 17, pp.75~98 (1991)
  3. "Depression in schizophrenia:recognition and management in the USA", 47, pp.185~197 (2001)
  4. "Developmentand prediction of postpsychotic depression in neuroleptictreatedschizophrenics", 39, pp.197~203 (1982)
  5. "Postpsychotic depression in schizophrenia", 33, pp.231~239 (1976)
  6. "Depression in schizophrenia perspective in the era of", pp.1379~1389
  7. "정신분열병의 경과 중 발생하는 우울증", 41, pp.421~429 (2002)
  8. "Cross-cultural adaptation and validation of the Spanish versionof the Calgary Depression Scale for Schizophrenia", 68, pp.349~356 (2004)
  9. "Depression in chronic schizophrenia", 142, pp.465~470 (1983)
  10. "A rating scale for depression", 23, pp.56~62
  11. "Exactly what does the HamiltonDepression Rating Scale measure", 27, pp.259~273 (1993)
  12. "Reliabilityand validity of a depression rating scale for schizophrenics", 6, pp.201~208 (1992)
  13. "A depression rating scale forschizophrenics", 3, pp.247~251 (1990)
  14. "The Calgary Depression Rating Scale for Schizophrenia:development and interrater reliability of a German version(CDSS-G)", 33, pp.433~443 (1999)
  15. "The Greek version of the calgarydepression scale for schizophrenia", 94, pp.163~171 (2000)
  16. "The Japanese version of theCalgary Depression Scale for Schizophrenics(JCDSS)", 52, pp.163~166
  17. "Validity study of theBrazilian version of the Calgary Depression Scale for Schizophrenia", 32, pp.41~49 (1998)
  18. "Comparison of four scales measuring depressionin schizophrenic inpatients", 15, pp.274~277 (2000)
  19. "정신분열증 환자의 우울증에 관한 연구", 20, pp.84~93 (1981)
  20. "양성 및 음성 정신분열증 입원환자에 있어서우울증의 성질과 빈도", 31, pp.106~112 (1992)
  21. "Clinical Handbook of PsychotropicDrugs", pp.106~109 (2004), Hogrefe and Huber Publishers
  22. "DSM-IV의 제1축 장애의 구조화된 면담" (2000), 서울,도서출판 하나의학사
  23. "한국판 양성 및 음성증후군척도(Positive and Negative Syndrome Scale)의신뢰도 및 타당도", 40, pp.1090~1105 (2001)
  24. "A rating scale for extrapyramidal side effects", 212 suppl, pp.11~19 (1970)
  25. "A new depression scale designed to besensitive to change", pp.382~389
  26. "우울증상을 수반한 만성 정신분열병 입원환자에서의 Paroxetine 효과:이중맹검 위약대조 연구", 39, pp.774~786 (2000)
  27. "문항반응 이론과 요인분석을 이용한 척도개발 및 타당화 99년도 임상심리학회 3차 workshop" (1999), 임상심리학회
  28. "Evaluation ofdepression in schizophrenia:psychometric properties of a French versionof the Calgary Depression Scale", 89, pp.123~132 (1999)
  29. "A psychometric comparisonof the Calgary Depression Scale for Schizophrenia and the HamiltonDepression Rating Scale", 19, pp.205~212 (1996)
  30. "Specificity of theCalgary Depression Scale for schizophrenics", 11, pp.239~244 (1994)

관련 논문AI추천

이 간행물의 다른 논문 (17건)